• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

4.980 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,022
Open 4.980
Bid (Size) 5.000 (3)
Ask (Size) 5.110 (5)
Prev. Close 4.980
Today's Range 4.980 - 4.980
52wk Range 2.645 - 8.275
Shares Outstanding 55,434,956
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 30, 2025
 
Via Benzinga
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst
September 15, 2025
Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining a Buy rating and $30 price target. 
Via Benzinga

Performance

YTD
-16.6%
-16.6%
1 Month
+18.3%
+18.3%
3 Month
+62.0%
+62.0%
6 Month
+55.1%
+55.1%
1 Year
-32.3%
-32.3%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
May 09, 2025
Via Benzinga
7 Analysts Assess Voyager Therapeutics: What You Need To Know
April 08, 2025
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
March 20, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
December 02, 2024
Via Benzinga
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
March 12, 2025
Via Benzinga
Earnings Scheduled For March 11, 2025
March 11, 2025
Via Benzinga
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
November 14, 2024
Via Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via Benzinga
Preview: Voyager Therapeutics's Earnings
November 11, 2024
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
October 16, 2024
Via Benzinga
VOYAGER ALERT: Bragar Eagel & Squire, P.C. is Investigating Voyager Therapeutics, Inc. on Behalf of Voyager Stockholders and Encourages Investors to Contact the Firm
February 24, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
February 20, 2025
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 22, 2024
Via Benzinga
What Analysts Are Saying About Voyager Therapeutics Stock
July 31, 2024
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
April 17, 2024
Via Chartmill
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
March 27, 2024
Via Chartmill
Get “Picky” With Stocks For September Profits
September 09, 2024
Via Talk Markets
3 High-Growth Stocks Poised To Double By Next Year
August 28, 2024
Via Talk Markets
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
Via InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
March 27, 2024
Via InvestorPlace
Delving into NASDAQ:VYGR's Growth Prospects.
March 26, 2024
Via Chartmill

Frequently Asked Questions

Is Voyager Therapeutics, Inc. - Common Stock publicly traded?
Yes, Voyager Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Voyager Therapeutics, Inc. - Common Stock trade on?
Voyager Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Voyager Therapeutics, Inc. - Common Stock?
The ticker symbol for Voyager Therapeutics, Inc. - Common Stock is VYGR on the Nasdaq Stock Market
What is the current price of Voyager Therapeutics, Inc. - Common Stock?
The current price of Voyager Therapeutics, Inc. - Common Stock is 4.980
When was Voyager Therapeutics, Inc. - Common Stock last traded?
The last trade of Voyager Therapeutics, Inc. - Common Stock was at 10/14/25 04:00 PM ET
What is the market capitalization of Voyager Therapeutics, Inc. - Common Stock?
The market capitalization of Voyager Therapeutics, Inc. - Common Stock is 276.07M
How many shares of Voyager Therapeutics, Inc. - Common Stock are outstanding?
Voyager Therapeutics, Inc. - Common Stock has 276M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.19
+0.00 (0.00%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap